Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Afatinib Recommended for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations
Afatinib Recommended for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations
Author
Oncology Times
Published
Fri 16 Feb 2024
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP60_020624.mp3.mp3
Share to:
